SCHEMBL15977833

SCHEMBL15977833

c1ccc(-c2ccccc2-c2c3ccccc3c(-c3ccccc3-c3ccccc3)c3cc(-c4ccc(-c5ccncc5)cn4)ccc23)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 3/20 0.46
IMPDH2 P12268 1/20 0.45
ACVR1 Q04771 1/20 0.40
NTRK1 P04629 2/20 0.39
AXL P30530 1/20 0.39
CDK8 P49336 1/20 0.39
TNIK Q9UKE5 1/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
KDR P35968 1/20 0.39
NOTUM Q6P988 1/20 0.39
HSD17B1 P14061 1/20 0.38
HSD17B2 P37059 1/20 0.38
MKNK1 Q9BUB5 1/20 0.38
DHODH Q02127 1/20 0.38
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
MAPK10 P53779 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15977930 1.00 PIK3CA (0.46) PIK3CAIMPDH2ACVR1NTRK1AXL
SCHEMBL15977818 0.91 DHODH (0.44) PIK3CAAXLCDK8TNIKCYP11B1
SCHEMBL15977534 0.90 CYP11B1 (0.44) PIK3CACYP11B1CYP11B2HSD17B1HSD17B2
SCHEMBL15977541 0.89 PIK3CA (0.43) PIK3CAIMPDH2ACVR1NTRK1CYP11B1
SCHEMBL15977581 0.88 DHODH (0.46) PIK3CACYP11B1CYP11B2MKNK1DHODH
SCHEMBL15977525 0.87 DHODH (0.42) AXLCDK8TNIKKDRDHODH
SCHEMBL15977611 0.87 PIK3CA (0.42) PIK3CAIMPDH2ACVR1CYP11B1CYP11B2
SCHEMBL15366741 0.86 PIK3CA (0.49) PIK3CAIMPDH2ACVR1CYP11B1CYP11B2
SCHEMBL15977853 0.86 PIK3CA (0.55) PIK3CAIMPDH2NOTUMMKNK1DHODH
SCHEMBL15977832 0.86 KDM4E (0.41) PIK3CAIMPDH2NTRK1CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 US disclosed
US-9559311-B2 Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment IDEMITSU KOSAN CO., LTD. (JP) 2017-01-31 US disclosed
US-9559311-B2 Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment IDEMITSU KOSAN CO., LTD. (JP) 2017-01-31 US disclosed
US-20140239273-A1 ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-08-28 US disclosed
US-20140239273-A1 ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 PIK3CA 2722/4885IMPDH2 3647/4885ACVR1 3843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.